ENDRA Life Sciences (NDRA) Net Income towards Common Stockholders (2016 - 2021)
Historic Net Income towards Common Stockholders for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' Net Income towards Common Stockholders fell 3793.68% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.4 million, marking a year-over-year increase of 634.21%. This contributed to the annual value of -$11.5 million for FY2024, which is 1439.03% down from last year.
- Per ENDRA Life Sciences' latest filing, its Net Income towards Common Stockholders stood at -$3.1 million for Q4 2021, which was down 3793.68% from -$2.7 million recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Net Income towards Common Stockholders registered a high of -$741623.0 during Q1 2017, and its lowest value of -$9.0 million during Q4 2019.
- Over the past 5 years, ENDRA Life Sciences' median Net Income towards Common Stockholders value was -$2.7 million (recorded in 2019), while the average stood at -$2.8 million.
- As far as peak fluctuations go, ENDRA Life Sciences' Net Income towards Common Stockholders plummeted by 28168.05% in 2019, and later soared by 7507.21% in 2020.
- ENDRA Life Sciences' Net Income towards Common Stockholders (Quarter) stood at -$2.3 million in 2017, then fell by 3.09% to -$2.4 million in 2018, then crashed by 281.68% to -$9.0 million in 2019, then skyrocketed by 75.07% to -$2.3 million in 2020, then plummeted by 37.94% to -$3.1 million in 2021.
- Its last three reported values are -$3.1 million in Q4 2021, -$2.7 million for Q3 2021, and -$3.2 million during Q2 2021.